PRESS RELEASES

Date Title and Summary View
Toggle Summary Alnylam and Isis Receive Exclusive License to Key microRNA Patents for Therapeutic Applications
Alnylam and Isis Receive Exclusive License to Key microRNA Patents for Therapeutic Applications Intellectual Property From Max Planck Society Strengthens Companies’ Leadership Positions In RNA-Based Drug Discovery and Development CAMBRIDGE, Mass., and CARLSBAD, Calif., Oct.
View HTML